Jingchun Fan

Dr. Jingchun Fan


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2015 in Environmental Science and Pollution Research
Verified
Journal Article
Closed access
PDF file
JFJingchun Fan
Jingchun Fan
SLShulan Li
Shulan Li
CFChunling Fan
Chunling Fan
ZBZhenggang Bai
Zhenggang Bai
KYKehu Yang
Kehu Yang

2 May 2024 in Trials
Verified
Journal Article
Open access
PDF file
HZHailiang Zhang
Hailiang Zhang
XZXiangrong Zhang
Xiangrong Zhang
XJXiaomei Jiang
Xiaomei Jiang
RDRunjing Dai
Runjing Dai
NZNa Zhao
Na Zhao
SBShisan Bao
Shisan Bao
Objective: To evaluate mindfulness-based intervention for hypertension with depression and/or anxiety. Methods: 10-week mindfulness-based intervention, including health education for hypertension, exclusively for the control group, was administered to the intervention group to assist sixty hypertension patients with depression/anxiety. Among them, the intervention group comprised 8 men and 22 women, with a mean age of 60.02 years and a mean duration of hypertension of 6.29 years. The control group consisted of 14 men and 16 women with a mean age of 57.68 years and a mean duration of hypertension of 6.32 years. The severity of depressive and/or anxiety symptoms was assessed using the 9-item Patient Health Questionnaire (PHQ-9) and the 7-item Generalized Anxiety Disorder scale (GAD-7), along with blood pressure (BP) measurements taken twice daily. The study utilized a self-made self-efficacy scale and awareness of physical and mental health to evaluate mental health and state. Results: The depression PHQ-9 or GAD-7 scores reduced by 21.1% or 17.8% in the mindfulness-based intervention group, compared to the control (Z = -2.040, P = 0.041) post 10-week period, suggesting significant reduction in anxiety/stress. These results were consistent with a reduction in systolic BP of 12.24 mm Hg (t = 6.041, P = 0.000). The self-efficacy score of the mindfulness intervention group significantly improved compared to the control (t = 7.818, P < 0.001), while the awareness of physical and mental health in the mindfulness intervention group significantly improved compared to the control (χ2 = 5.781, P = 0.016). Conclusion: Mindfulness-based, short-term focused interventions provide modest relief for depression and/or anxiety and are effective in lowering blood pressure and improving self-efficacy scores. Trial registration: Chinese Clinical Trial Registry, ChiCTR1900028258. Registered 16 December 2019, https://www.chictr.org.cn/showproj.html?proj=43627.

5 March 2013 in Asia Pacific Journal of Public Health
Verified
Journal Article
Closed access
PDF file
CWChenggang Wang
Chenggang Wang
WYWeizhong Yang
Weizhong Yang
JFJingchun Fan
Jingchun Fan
FWFurong Wang
Furong Wang
BJBaofa Jiang
Baofa Jiang
QLQiyong Liu
Qiyong Liu
The aim of the study was to describe the spatial and temporal patterns of dengue in Guangdong for 1978 to 2010. Time series analysis was performed using data on annual dengue incidence in Guangdong province for 1978-2010. Annual average dengue incidences for each city were mapped for 4 periods by using the geographical information system (GIS). Hot spot analysis was used to identify spatial patterns of dengue cases for 2005-2010 by using the CrimeStat III software. The incidence of dengue in Guangdong province had fallen steadily from 1978 to 2010. The time series was a random sequence without regularity and with no fixed cycle. The geographic range of dengue fever had expanded from 1978 to 2010. Cases were mostly concentrated in Zhanjiang and the developed regions of Pearl River Delta and Shantou.

1 September 2020 in Travel Medicine and Infectious Disease
Verified
Journal Article
Closed access
JFJingchun Fan
Jingchun Fan
Xiaodong LiuXiaodong Liu
Xiaodong Liu
GSGuojun Shao
Guojun Shao
JQJunpin Qi
Junpin Qi
YLYi Li
Yi Li
SBShisan Bao
Shisan Bao

24 October 2024 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
TFTiantian Feng
Tiantian Feng
JCJuan Cao
Juan Cao
XMXiaoting Ma
Xiaoting Ma
XWXinhua Wang
Xinhua Wang
XGXiaolong Guo
Xiaolong Guo
JFJingchun Fan
Jingchun Fan
Objective: Experimental animal models have been used for decades to study the development and progression of chronic obstructive pulmonary disease (COPD). However, there is a lack of methods for constructing animal models of COPD for optimal modelling. This systematic literature review (SLR) aimed to assess the various methods used to establish COPD animal models, highlight their advantages and limitations, and explore more optimized approaches for establishing such models.Methods: A systematic search was performed in four English databases (PubMed, Embase, Web of Science, and the Cochrane Library) and four Chinese databases (Chinese Biomedical Literature Database, China National Knowledge Infrastructure, China Science and Technology Journal Database, and Wanfang Database). Of the 8,015 retrieved full-text manuscripts, 453 were selected.Results: Smoking (n = 140), smoking combined with lipopolysaccharide (LPS) (n = 275), smoking combined with protease drip (PPE) (n = 10), smoking combined with bacteria (n = 23), and smoking combined with particulate matter (PM2.5) (n = 5) were the most used methods for establishing animal models of COPD. Rats and mice were the most frequently selected experimental animals, with male animals accounting for 79.47% of the total. A total of 92.49 and 29.14% of the articles reviewed considered lung pathology of experimental animals only and lung pathology and lung function tests, respectively.Conclusion: Our review suggests that the best way to establish an animal model of COPD is to combine smoking with LPS. Although findings from animal models of COPD cannot be directly extrapolated to human COPD, they could provide useful tools for further investigation into human COPD disease.Systematic review registration: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023407555, Identifier PROSPERO CRD42023407555.

16 June 2021 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
RDRunjing Dai
Runjing Dai
YCYongchun Cao
Yongchun Cao
HZHailiang Zhang
Hailiang Zhang
NZNa Zhao
Na Zhao
DRDong Ren
Dong Ren
JFJingchun Fan
Jingchun Fan
Objectives. To evaluate the efficacy and/or safety of acupuncture therapy (AT) in quitting smoking. Methods. Randomized controlled trials (RCTs) were searched in PubMed, Cochrane Library, Embase, Web of Science, and Chinese Biomedical Database (CBM). We used Cochrane Collaborative Quality Assessment to assess the risk of bias. Bayesian network meta-analysis was utilized to evaluate the efficacy and safety of different interventions. Data analyses were conducted using WinBUGS 1.4.3, Stata 14, and RevMan 5.3.5 software. Results. A total of 2706 patients from 23 studies were included, involving 6 treatment arms. Network meta-analysis demonstrated that there was no significant difference in short-term abstinence rates or changes in Fagerstrom test for nicotine dependence (FTND) scores and daily smoking among these groups (AT, sham acupuncture therapy (SAT), auricular acupressure (AA), sham auricular acupressure (SAA), acupuncture plus auricular acupressure (APAA), and nicotine replacement therapy (NRT)). However, there was a significant difference between SAA and AA with risk ratio (RR) of 2.49 (95 CI 1.14, 5.97) in long-term abstinence rate. The probabilistic ranking results showed that APAA and AA were superior to other interventions in the comparison of abstinence rates. There was no obvious inconsistency between the direct comparison and indirect comparison, using the consistency test. Conclusion. AA was superior to SAA in smoke quitting, but there was no difference among other interventions in long-term truncation rates. There was no difference in short-term abstinence rates among these selected groups. We need large sample RCTs to clarify the advantages of interventions such as APAA and AA. In addition, reporting of adverse events that may occur during treatment also should be enhanced to complement evidence-based medicine. The trial is registered with PROSPERO CRD42020164712.